Abstract
Matrix metalloproteinases (MMPs) have been implicated in both normal and pathologic processes. In cancer in particular, in vitro and animal studies showed an involvement of MMPs in many stages of cancer progression. This led to the development of MMP inhibitors that in most cases failed in clinical trials. In this review we go over the role of MMPs in the different stages of cancer progression and try to understand why the early generation of MMP inhibitors failed. The analysis of the lessons from this first experience, plus the review of the current knowledge that shows that MMPs may be pro-or anti-tumorigenic may set the stage for a future success for this therapeutic strategy in cancer.
Keywords: Cancer, clinical trials, matrix metalloproteinases, MMP inhibitors, therapy, therapeutic strategy, anti-tumorigenic, Malignant tumors, bind amino acid, glycosylphosphatidylinositol anchor, vascular and inflammatory cells, plasminogen-null mice, intramolecular autolytic, plasminogen-activating enzyme, Plasmin
Current Pharmaceutical Biotechnology
Title: Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Volume: 12 Issue: 11
Author(s): D. Raffo, O. Pontiggia and M. Simian
Affiliation:
Keywords: Cancer, clinical trials, matrix metalloproteinases, MMP inhibitors, therapy, therapeutic strategy, anti-tumorigenic, Malignant tumors, bind amino acid, glycosylphosphatidylinositol anchor, vascular and inflammatory cells, plasminogen-null mice, intramolecular autolytic, plasminogen-activating enzyme, Plasmin
Abstract: Matrix metalloproteinases (MMPs) have been implicated in both normal and pathologic processes. In cancer in particular, in vitro and animal studies showed an involvement of MMPs in many stages of cancer progression. This led to the development of MMP inhibitors that in most cases failed in clinical trials. In this review we go over the role of MMPs in the different stages of cancer progression and try to understand why the early generation of MMP inhibitors failed. The analysis of the lessons from this first experience, plus the review of the current knowledge that shows that MMPs may be pro-or anti-tumorigenic may set the stage for a future success for this therapeutic strategy in cancer.
Export Options
About this article
Cite this article as:
Raffo D., Pontiggia O. and Simian M., Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances, Current Pharmaceutical Biotechnology 2011; 12 (11) . https://dx.doi.org/10.2174/138920111798377085
DOI https://dx.doi.org/10.2174/138920111798377085 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Leukocytes in Diabetic Retinopathy
Current Diabetes Reviews Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Proteomics and Cardiovascular Disease: An Update
Current Medicinal Chemistry Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium
Current Signal Transduction Therapy Prospective for Diagnosis and Treatment of Diabetic Retinopathy
Current Pharmaceutical Design The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis
Current Medical Imaging Association of Large Vessel Aneurysm/Pseudo-Aneurysm/Aortitis and Deep Vein Thrombosis in Patients with Behçet’s Disease: A Case Report
Current Rheumatology Reviews Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Reading and Writing the Blood-Brain Barrier: Relevance to Therapeutics
Recent Patents on CNS Drug Discovery (Discontinued) Angiotensin II and the Cardiac Complications of Diabetes Mellitus
Current Pharmaceutical Design Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry 3D Printing in Medical Applications
Current Medical Imaging Abnormal Peri-Organ or Intra-organ Fat (APIFat) Deposition: An Underestimated Predictor of Vascular Risk?
Current Vascular Pharmacology “Bridge Proteins” Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics
Current Protein & Peptide Science Estrogenic Compounds, Estrogen Receptors and Vascular Cell Signaling in the Aging Blood Vessels
Current Medicinal Chemistry Re-Wiring the Circuit: Mitochondria as a Pharmacological Target in Liver Disease
Current Medicinal Chemistry Drug Therapy for Abdominal Aortic Aneurysms Utilizing Omega-3 Unsaturated Fatty Acids and Their Derivatives
Current Drug Targets Meet Our Editor:
Current Cardiology Reviews Nimodipine Reappraised: An Old Drug With a Future
Current Neuropharmacology